Riordan Neil H, Ambrozic Richard A, Paz-Rodríguez Jorge
Stem Cell Institute - BICSA Financial Tower Aquilino de la Guardia, Panama City, Panama.
REGENCare - 240 Pharr Rd NE Atlanta GA 30305, USA.
Am J Transl Res. 2022 Jul 15;14(7):4855-4859. eCollection 2022.
Immunoglobulin A nephropathy is an inflammatory, autoimmune condition that may lead to renal impairment in its most aggressive forms. In this case report, a 50-year-old male with acute renal failure was diagnosed with IgA nephropathy, having elevated creatinine levels (3.0 mg/dL) and hypertension. He received intravenous infusions of a total of 120 million umbilical cord-derived mesenchymal stem cells (UC-MSCs) and was followed-up for 6 months. No adverse events were reported during or after administration or any of the follow-up visits. Creatinine levels decreased to and remained normal (1.0 mg/dL) in the 6 months following treatment. Anti-hypertensive medications were no longer needed. UC-MSC administration was safe, well-tolerated, and beneficial for this patient with IgA nephropathy.
免疫球蛋白A肾病是一种炎症性自身免疫性疾病,最严重的情况下可能导致肾功能损害。在本病例报告中,一名50岁的急性肾衰竭男性被诊断为免疫球蛋白A肾病,肌酐水平升高(3.0mg/dL)且患有高血压。他接受了总共1.2亿个脐带间充质干细胞(UC-MSCs)的静脉输注,并进行了6个月的随访。给药期间、给药后或任何一次随访中均未报告不良事件。治疗后的6个月内,肌酐水平降至并维持在正常水平(1.0mg/dL)。不再需要抗高血压药物。对于该免疫球蛋白A肾病患者,输注脐带间充质干细胞是安全的,耐受性良好且有益。